An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy

Stephen M. Chrzanowski; Meghan M. McAnally; Peter B. Kang

doi:10.1001/jamaneurol.2021.1782

An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy

Stephen M. Chrzanowski, Meghan M. McAnally, Peter B. Kang

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	901-902
Number of pages	2
Journal	JAMA Neurology
Volume	78
Issue number	8
DOIs	https://doi.org/10.1001/jamaneurol.2021.1782
State	Published - Aug 1 2021

Bibliographical note

Funding Information:
personal fees from Sarepta Therapeutics (advisory board) and Novartis/AveXis (consultant) and grant funding from ML Bio Solutions outside the submitted work. No other disclosures were reported.

PubMed: MeSH publication types

Editorial

Publisher link

10.1001/jamaneurol.2021.1782

Find It

Find It at U of M Libraries

Cite this

@article{370904ffd8b04d079ae64ef5e7d15582,

title = "An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy",

author = "Chrzanowski, {Stephen M.} and McAnally, {Meghan M.} and Kang, {Peter B.}",

note = "Funding Information: personal fees from Sarepta Therapeutics (advisory board) and Novartis/AveXis (consultant) and grant funding from ML Bio Solutions outside the submitted work. No other disclosures were reported.",

year = "2021",

month = aug,

day = "1",

doi = "10.1001/jamaneurol.2021.1782",

language = "English (US)",

volume = "78",

pages = "901--902",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy

AU - Chrzanowski, Stephen M.

AU - McAnally, Meghan M.

AU - Kang, Peter B.

N1 - Funding Information: personal fees from Sarepta Therapeutics (advisory board) and Novartis/AveXis (consultant) and grant funding from ML Bio Solutions outside the submitted work. No other disclosures were reported.

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85108555021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108555021&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2021.1782

DO - 10.1001/jamaneurol.2021.1782

M3 - Comment/debate

C2 - 34152378

AN - SCOPUS:85108555021

SN - 2168-6149

VL - 78

SP - 901

EP - 902

JO - JAMA Neurology

JF - JAMA Neurology

IS - 8

ER -

An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy

Bibliographical note

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this